Table 1.

Epidemiologic and Program Data for Zambia

Variable	Value	Source
Population (2005)	11,478,000	[56]
Live births/1,000 population (2007)	40.78	[57]
Live births per year	468,073	Calculated from [56,57]
Percent of global BCG vaccine coverage	0.398%	[34]
Percent of target population vaccinated with BCG	92%	[34]
Gross National Income per capita (US$) 2005	$500	[58]
Life expectancy at birth (years)	38.4	[58]
All cause mortality	Age specific	[59]
New estimated TB smear-positive incidence per 100,000 (2005)	247	[1]
Annual risk of TB infection (ARI)	4.94%	Calculated from [1,16]
Probability of being diagnosed and treated for LTBI	1%	[20]*
Completion of LTBI treatment	67%	[21]
HIV prevalence (2006)	9.4%	[10]
HIV incidence per annum	0.96%	Calculated from [22]
DOTS coverage (2005)	100%	[1]
DOTS case detection rate (2005)	52%	[1]
Initial drug resistance
Single drug resistance	8.5%	[60]
Multi drug resistance†	1.8%	[61]
DOTS new case treatment outcomes (2005)		[1]
Cure/complete	83%
Default/transfer/not evaluated	8%
Die	8%
Fail	1%
DOTS re-treatment outcomes (2005)		[1]
Cure/complete	78%
Default/transfer/not evaluated	7%
Die	13%
Fail	2%

*This assumes only dually infected individuals (HIV and TB) whose HIV infection is detected and are tuberculin tested will be treated (based on a Haitian study)

†Defined as resistance to isoniazid and rifampin, with or without other drug resistance